563 related articles for article (PubMed ID: 19507885)
1. Switching between kappa(2) and kappa(3) bis(pyrazol-1-yl)acetate ligands by tuning reaction conditions: synthesis, spectral, electrochemical, structural, and theoretical studies on arene-Ru(II) derivatives of bis(azol-1-yl)acetate ligands.
Marchetti F; Pettinari C; Cerquetella A; Cingolani A; Pettinari R; Monari M; Wanke R; Kuznetsov ML; Pombeiro AJ
Inorg Chem; 2009 Jul; 48(13):6096-108. PubMed ID: 19507885
[TBL] [Abstract][Full Text] [Related]
2. Areneruthenium(II) 4-acyl-5-pyrazolonate derivatives: coordination chemistry, redox properties, and reactivity.
Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Cingolani A; Chan EJ; Kozawa K; Skelton BW; White AH; Wanke R; Kuznetsov ML; Martins LM; Pombeiro AJ
Inorg Chem; 2007 Oct; 46(20):8245-57. PubMed ID: 17727269
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and intramolecular and interionic structural characterization of half-sandwich (arene)ruthenium(II) derivatives of bis(pyrazolyl)alkanes.
Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Di Nicola C; Macchioni A; Zuccaccia D; Monari M; Piccinelli F
Inorg Chem; 2008 Dec; 47(24):11593-603. PubMed ID: 18998632
[TBL] [Abstract][Full Text] [Related]
4. New RuII (arene) complexes with halogen-substituted bis- and tris(pyrazol-1-yl)borate ligands.
Orbisaglia S; Di Nicola C; Marchetti F; Pettinari C; Pettinari R; Martins LM; Alegria EC; da Silva MF; Rocha BG; Kuznetsov ML; Pombeiro AJ; Skelton BW; Sobolev AN; White AH
Chemistry; 2014 Mar; 20(13):3689-704. PubMed ID: 24616192
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium(II) arene anticancer complexes with redox-active diamine ligands.
Bugarcic T; Habtemariam A; Deeth RJ; Fabbiani FP; Parsons S; Sadler PJ
Inorg Chem; 2009 Oct; 48(19):9444-53. PubMed ID: 19780621
[TBL] [Abstract][Full Text] [Related]
6. Ruthenium(II) and ruthenium(IV) complexes containing kappa1-P-, kappa2-P,O-, and kappa3-P,N,O-iminophosphorane-phosphine ligands Ph2PCH2P[=NP(=O)(OR)2]Ph2 (R = Et, Ph): synthesis, reactivity, theoretical studies, and catalytic activity in transfer hydrogenation of cyclohexanone.
Cadierno V; Crochet P; Díez J; García-Alvarez J; García-Garrido SE; Gimeno J; García-Granda S; Rodríguez MA
Inorg Chem; 2003 May; 42(10):3293-307. PubMed ID: 12739971
[TBL] [Abstract][Full Text] [Related]
7. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
[TBL] [Abstract][Full Text] [Related]
8. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
Reisner E; Arion VB; Guedes da Silva MF; Lichtenecker R; Eichinger A; Keppler BK; Kukushkin VY; Pombeiro AJ
Inorg Chem; 2004 Nov; 43(22):7083-93. PubMed ID: 15500346
[TBL] [Abstract][Full Text] [Related]
9. Diastereospecific and diastereoselective syntheses of Ruthenium(II) complexes using N,N' bidentate ligands aryl-pyridin-2-ylmethyl-amine ArNH-CH2-2-C5H4N and their oxidation to imine ligands.
Gómez J; García-Herbosa G; Cuevas JV; Arnaiz A; Carbayo A; Muñoz A; Falvello L; Fanwick PE
Inorg Chem; 2006 Mar; 45(6):2483-93. PubMed ID: 16529469
[TBL] [Abstract][Full Text] [Related]
10. Mixed-valent metals bridged by a radical ligand: fact or fiction based on structure-oxidation state correlations.
Sarkar B; Patra S; Fiedler J; Sunoj RB; Janardanan D; Lahiri GK; Kaim W
J Am Chem Soc; 2008 Mar; 130(11):3532-42. PubMed ID: 18290644
[TBL] [Abstract][Full Text] [Related]
11. Heteroleptic arene ruthenium complexes based on meso-substituted dipyrrins: synthesis, structure, reactivity, and electrochemical studies.
Yadav M; Singh AK; Maiti B; Pandey DS
Inorg Chem; 2009 Aug; 48(16):7593-603. PubMed ID: 19610658
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structure and spectral and redox properties of new mixed ligand monomeric and dimeric Ru(II) complexes: predominant formation of the "cis-alpha" diastereoisomer and unusual 3MC emission by dimeric complexes.
Murali M; Palaniandavar M
Dalton Trans; 2006 Feb; (5):730-43. PubMed ID: 16429178
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial activity of ruthenium(II) and osmium(II) arene complexes with mono- and bidentate chloroquine analogue ligands.
Ekengard E; Glans L; Cassells I; Fogeron T; Govender P; Stringer T; Chellan P; Lisensky GC; Hersh WH; Doverbratt I; Lidin S; de Kock C; Smith PJ; Smith GS; Nordlander E
Dalton Trans; 2015 Nov; 44(44):19314-29. PubMed ID: 26491831
[TBL] [Abstract][Full Text] [Related]
14. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
[TBL] [Abstract][Full Text] [Related]
15. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
[TBL] [Abstract][Full Text] [Related]
16. 2,2'-Dipyridylketone (dpk) as ancillary acceptor and reporter ligand in complexes [(dpk)(Cl)Ru(mu-tppz)Ru(Cl)(dpk)]n+ where tppz = 2,3,5,6-tetrakis(2-pyridyl)pyrazine.
Ghumaan S; Sarkar B; Chanda N; Sieger M; Fiedler J; Kaim W; Lahiri GK
Inorg Chem; 2006 Sep; 45(19):7955-61. PubMed ID: 16961390
[TBL] [Abstract][Full Text] [Related]
17. Novel ruthenium(ii) complexes containing the N-phosphorylated iminophosphorane-phosphine ligand Ph(2)PCH(2)P{[double bond, length as m-dash]NP([double bond, length as m-dash]O)(OEt)(2)}Ph(2): a new coordination mode of its methanide anion.
Cadierno V; Díez J; García-Alvarez J; Gimeno J; Rubio-García J
Dalton Trans; 2008 Nov; (42):5737-48. PubMed ID: 18941661
[TBL] [Abstract][Full Text] [Related]
18. Iron(III) complexes of tripodal monophenolate ligands as models for non-heme catechol dioxygenase enzymes: correlation of dioxygenase activity with ligand stereoelectronic properties.
Mayilmurugan R; Visvaganesan K; Suresh E; Palaniandavar M
Inorg Chem; 2009 Sep; 48(18):8771-83. PubMed ID: 19694480
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, crystal structure and preliminary reactivity behaviour of new heteropolytopic ligands based on the 1,3,5-triazine spacer and pyrazolyl, tris-pyrazolylmethyl and tris-pyrazolylethoxy bonding fragments.
Di Nicola C; Garau F; Marchetti F; Monari M; Pandolfo L; Pettinari C; Venzo A
Dalton Trans; 2011 May; 40(18):4941-53. PubMed ID: 21445439
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, spectroscopic characterization, electrochemical behaviour and antibacterial activity of Ru(III) complexes of 2-[(4-N,N'-dimethylaminophenylimino)-methyl]-4-halophenol.
Puthilibai G; Vasudhevan S; Kutti Rani S; Rajagopal G
Spectrochim Acta A Mol Biomol Spectrosc; 2009 May; 72(4):796-800. PubMed ID: 19112044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
